Retrieved from:
http://www.plainsite.org/dockets/download.html?
id=210572493&z=6afa4594
|
Case Name: Stemgenix, Inc v. Balshi
California Southern District Court
Case No. 3:15-cv-00411
Filed 02/24/2015
Recently, I found that Dr. Thomas Balshi is currently being sued by a rival stem cell company StemGenex, Inc for trademark infringement and breach of contract. The prosecution accuses Balshi of supposedly violating a contract between him and StemGenex. The contract entailed that StemGenex would refer patients to Balshi, and he would perform the stem cell procedures, given a "predetermined price." This went into effect on August 30, 2012. StemGenex claims that Balshi violated their contract by diverting their referred patients to Stemedix.
Although we should not jump to any conclusions before a verdict is reached, if the allegations against Dr. Balshi ARE valid and Stemedix IS in fact more of a stem cell therapy consulting company, this would mean Balshi would be making double the profit (profit from Stemedix consulting and profit from providing separate stem cell therapies).
After examine a number of of the weblog posts in your website now, and I actually like your method of blogging. I bookmarked it to my bookmark website checklist and can be checking again soon. Pls try my site as nicely and let me know what you think. Elia & Ponto
ReplyDeleteYou should participate in a contest for among the best blogs on the web. I will suggest this website! GPW Law
ReplyDelete